Expression of the osmotically responsive cationic channel TRPV4 in the endolymphatic sac

Audiology and Neurotology

Volumn 14, Issue 3, 2009, Pages 190-197

  Kumagami, H ^a   Terakado, M ^a   Sainoo, Y ^a   Baba, A ^a   Fujiyama, D ^a   Fukuda, T ^a   Takasaki, K ^a   Takahashi, H ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Endolymphatic sac; M ni re's disease; Osmolarity; Transient receptor potential vanilloid 4

Indexed keywords

VANILLOID RECEPTOR 4;

ACOUSTIC NEURINOMA; ADULT; ANIMAL CELL; ANIMAL TISSUE; APICAL MEMBRANE; ARTICLE; CELL VOLUME; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOLYMPHATIC SAC; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MENIERE DISEASE; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TISSUE CULTURE;

ADULT; ANIMALS; ENDOLYMPHATIC SAC; HOMEOSTASIS; HUMANS; IMMUNOHISTOCHEMISTRY; MENIERE DISEASE; MIDDLE AGED; MITOCHONDRIAL MEMBRANES; NEUROMA, ACOUSTIC; RATS; TRPV CATION CHANNELS;

EID: 63449114130     PISSN: 14203030     EISSN: 14219700     Source Type: Journal    
DOI: 10.1159/000180290     Document Type: Article

References (35)

1. American Academy of Otolaryngology-Head and Neck Foundation Inc: Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Ménière's disease. Otolaryngol Head Neck Surg 1995; 113: 181-185.
2. Andrade YN, Fernandes J, Vázquez E, Fernández- Fernández JM, Arniges M, Sánchez TM, Villalón M, Valverde MA: TRPV4 channel is involved in the coupling of fluid viscosity changes to epithelial ciliary activity. J Cell Biol 2005; 168: 869-874.
3. Arenberg IK, Norback DH: Ultrastructural pathology of endolymphatic sac biopsy specimens correlated with the clinical stage in Ménière's disease. Rev Laryngol Otol Rhinol (Bord) 1981; 102: 237-239.
4. Arniges M, Vázquez E, Fernández-Fernández JM, Valverde MA: Swelling-activated Ca 2+ entry via TRPV4 channel is defective in cystic fibrosis airway epithelia. J Biol Chem 2004; 279: 54062-54068.
5. Becker D, Blase C, Bereiter-Hahn J, Jendrach M: TRPV4 exhibit a functional role in cell-volume regulation. J Cell Sci 2005; 118: 2435-2440.
6. Caldwell RA, Clemo HF, Baumgarten CM: Using gadolinium to identify stretch-activated channels: technical considerations. Am J Physiol 1998; 272:C619-C621.
7. Cohen DM: TRPV4 and the mammalian kidney: Pflugers Arch 2005; 451: 168-175.
8. Danckwardt-Lillieström N, Laurent C, Hellström S, Friberg U, Kinnefors A, Rask-Andersen H: Localization of hyaluronan in the human endolymphatic sac. A study using the affinity hyaluronan binding protein. Acta Otolaryngol (Stockh) 1994;114:382-386.
9. Danckwardt-Lillieström N, Friberg U, Kinnefors A, Rask-Andersen H: 'Endolymphatic saccitis' in a case of active Ménière's disease: an ultrastructural histopathologic investigation. Ann Otol Rhinol Laryngol 1997; 106: 190-198.
10. Danckwardt-Lillieström N, Friberg U, Kinnefors A, Rask-Andersen H: Ultrastrucural analysis of 20 intraosseous endolymphatic sacs from patients with cerebello-pontine angle tumours: a surgically obtained control material for histopathological studies. Auris Nasus Larynx 2000; 27: 311-321.
11. Danckwardt-Lillieström N, Laurent C, Hellström S, Friberg U, Kinnefors A, Rask-Andersen H: Localization of hyaluronan in the human endolymphatic sac: a study using the affinity hyaluronan binding protein. Acta Otolaryngol (Stockh) 1994; 114: 382-386.
12. Dornhoffer JL, Danner C, Li S: Natriuretic peptide receptors in the human endolymphatic sac. Arch Otolaryngol Head Neck Surg 2002; 128: 379-383.
13. 4 - subunit and carbonic anhydrase II in epithelial cells of the murine endolymphatic sac. J Histochem Cytochem 2004; 52: 1377-1384.
14. Godlowski Z: Hyperosmosis of endolymph as primary pathogenic mechanism of Ménière's disease and clinical management. Acta Otolaryngol Suppl 1972; 299: 1-36.
15. Hallpike CS, Cairns H: Observations on the pathology of Ménière's syndrome. J Laryngol Otol 1938; 53: 625-655.
16. Hebbar GK, Rask-Andersen H, Linthicum FH Jr: Three-dimensional analysis of 61 human endolymphatic ducts and sacs in ears with and without Ménière's disease. Ann Otol Rhinol Laryngol 1991; 100: 219-225.
17. Kim J, Chung YD, Park YD, Choi S, Shin DW, Soh H, Lee HW, Son W, Yim J, Park CS, Kernan MJ, Kim C: A TRPV family ion channel required for hearing in Drosophila . Nature 2003; 424: 81-84.
18. Klockhoff I, Lindblom U: Endolymphatic hydrops revealed by glycerol test: preliminary report. Acta Otolaryngol 1966; 61: 459-462.
19. Kumagami H: Scanning electron microscopy and immunoglobulins of the endolymphatic sac in normal human subjects and sensorineural deafness: with special reference to Ménière's disease. Acta Otolaryngol Suppl 1990; 474: 1-21.
20. Kumagami H, Löwenheim H, Beitz E, Wild K, Schwartz H, Yamashita K, Schultz J, Paysan J, Zenner HP, Ruppersberg JP: The effect of anti-diuretic hormone on the endolymphatic sac of the inner ear. Pflugers Arch 1998; 436: 970-975.
21. Lang F, Busch GL, Ritter M, Völkl H, Waldegger S, Gulbins E, Häussinger D: Functional significance of cell volume regulatory mechanisms. Physiol Rev 1998; 78: 247-306.
22. Liedtke W: TRPV4 as osmosensor: a transgenic approach. Pflugers Arch 2005; 451: 176-180.
23. Lim D, Glasscock MI: Fine morphology of the endolymphatic sac in Ménière's disease; in Vosteen KH, et al (eds): Ménière's Disease: Pathogensis, Diagnosis and Treatment. Stuttgart, Thieme, 1981, pp 115-127.
24. Liu X, Bandyopadhyay BC, Nakamoto T, Singh B, Liedtke W, Melvin JE, Ambudkar I: A role for AQP5 in activation of TRPV4 by hypotonicity: concerted involvement of AQP5 and TRPV4 in regulation of cell volume recovery. J Biol Chem 2006; 281: 15485-15495.
25. Mizuno A, Matsumoto N, Imai M, Suzuki M: Impaired osmotic sensation in mice lacking TRPV4. Am J Physiol Cell Physiol 2003; 285: C96-C101.
26. O'Neil RG, Heller S: The mechanosensitive nature of TRPV channels. Pflugers Arch 2005; 451: 193-203.
27. Peters TA, Tonnaer EL, Kuijpers W, Cremers CW, Curfs JH: Differences in endolymphatic sac mitochondria-rich cells indicate specific functions. Laryngoscope 2002; 112: 534-541.
28. Qvortrup K, Rostraard J, Bretlau P: Ultrastructure of the endolymphatic sac in the rat with a proposal for a new cell nomenclature; in Filipo R, Barbara M (eds): Ménière's Disease: Perspective in the '90s. Amsterdam, Kugler, 1994, pp 427-433.
29. Qvortrup K, Rostgaard J, Holstein-Rathlou NH: The inner ear produces a natriuretic hormone. Am J Physiol 1996; 270:F1073-F1077.
30. Schindler RA, Horn KL, Leaky-Jones P, Maglio M: The ultrastructure of the endolymphatic sac in Ménière's disease. Laryngoscope 1979; 89: 95-107.
31. Tabuchi K, Suzuki M, Mizuno A, Hara A: Hearing impairment in TRPV4 knockout mice. Neurosci Lett 2005; 382: 304-308.
32. Takumida M, Kubo N, Ohtani M, Suzuka Y, Anniko M: Transient receptor potential channels in the inner ear: presence of transient receptor potential channel subfamily 1 and 4 in the guinea pig inner ear. Acta Otolaryngol 2005; 125: 929-934.
33. Tian W, Salanova M, Xu H, Lindsley JN, Oyama TT, Anderson S, Bachmann S, Cohen DM: Renal expression of osmotically responsive cation channel TRPV4 is restricted to waterimpermeant nephron segments. Am J Physiol Renal Physiol 2004; 287:F17-F24.
34. Wackym PA, Linthicum FH Jr, Ward PH, House WF, Micevych PE, Bagger-Sjöbäck D: Reevaluation of the role of the human endolymphatic sac in Ménière's disease. Otolaryngol Head Neck Surg 1990; 102: 732-744.
35. Zechner G, Altmann F: Histological studies on the human endolymphatic duct and sac. Pract Otorhinolaryngol (Basel) 1969; 31: 65-83.